In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Breathe Technologies brings in $23mm through its Series C round

Executive Summary

Respiratory device company Breathe Technologies Inc. has raised $23mm through the closing of its Series C venture round. DAG Ventures led and was joined by fellow new investor Johnson & Johnson Development Corp. (both will contribute one board member) and current shareholders Kleiner Perkins Caufield & Byers, Delphi Ventures, and Synergy Partners International.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Rehabilitation Equipment and Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies